LINC01004: A Drug Target / Disease Biomarker (G100216546)

Target Name: LINC01004

NCBI ID: G100216546

LINC01004

Other Name(s): long intergenic non-protein coding RNA 1004 | Long intergenic non-protein coding RNA 1004

LINC01004: A Drug Target / Disease Biomarker

LINC01004 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

LINC01004 is a small non-coding RNA molecule that is expressed in a variety of tissues and cells. It is typically expressed in high levels in brain and nervous system tissues and has been shown to play a role in the development and progression of these diseases.

One of the most promising aspects of LINC01004 is its potential as a drug target. LINC01004 has been shown to interact with a variety of protein molecules, including the protein known as FAK. FAK is a protein that is known to be involved in many different processes in the body, including cell adhesion, migration, and invasion.

Research has also shown that LINC01004 can interact with the protein known as PDGFR-尾, which is a protein that is involved in the development and progression of many different diseases, including cancer.

In addition to its potential as a drug target, LINC01004 has also been shown to be a potential biomarker. Studies have shown that LINC01004 levels can be detected in a variety of tissues and fluids, including blood, urine, and tissue samples from cancer patients. This suggests that LINC01004 could be used as a biomarker for cancer diagnosis and treatment.

Overall, LINC01004 is a promising molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its role in these processes and to develop safe and effective treatments for the diseases it is involved in.

Protein Name: Long Intergenic Non-protein Coding RNA 1004

The "LINC01004 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01004 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets